Transgene S.A.

Transgene S.A.verified

TRGNF

Price:

$0.85

Market Cap:

$108.87M

Transgene S.A. is a biotechnology company dedicated to the creation and advancement of therapeutic vaccines and oncolytic viruses. Its core mission is to develop innovative treatments for both cancer and various infectious diseases. The company's drug development pipeline includes several promising candidates: TG4050, a therapeutic vaccine, is currently in early-stage Phase I clinical trials for its potential use against ovarian cancer and certain types of HPV-negative head and neck cancers. TG4001, another therapeutic vaccine, has progressed to Phase II clinical trials, where it is being evaluated for the treatment of HPV-positive cancers. TG6002, an oncolytic virus, is undergoing Phase I/I...[Read more]

Industry

Biotechnology

IPO Date

2021-01-08

Stock Exchange

OTC

Ticker

TRGNF

The Enterprise Value as of June 2026 (TTM) for Transgene S.A. (TRGNF) is 104.27M

According to Transgene S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 104.27M. This represents a change of -6.76% compared to the average of 111.83M of the last 4 quarters.

Transgene S.A. (TRGNF) Historical Enterprise Value (quarterly & annually)

How has TRGNF Enterprise Value performed in the past?

The mean historical Enterprise Value of Transgene S.A. over the last ten years is 161.17M. The current 104.27M Enterprise Value has changed 6.37% with respect to the historical average. Over the past ten years (40 quarters), TRGNF's Enterprise Value was at its highest in in the December 2009 quarter at 395.07M. The Enterprise Value was at its lowest in in the June 2006 quarter at 0.

Quarterly (TTM)
Annual

Average

161.17M

Median

152.53M

Minimum

73.06M

Maximum

229.36M

Transgene S.A. (TRGNF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Transgene S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 83.35%

Maximum Annual Enterprise Value = 229.36M

Minimum Annual Increase = -41.42%

Minimum Annual Enterprise Value = 73.06M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025133.95M83.35%
202473.06M-41.42%
2023124.73M-23.49%
2022163.02M-28.92%
2021229.36M66.38%
2020137.86M-2.95%
2019142.04M-29.47%
2018201.38M-7.80%
2017218.42M16.28%
2016187.84M44.82%

Transgene S.A. (TRGNF) Average Enterprise Value

How has TRGNF Enterprise Value performed in the past?

The current Enterprise Value of Transgene S.A. (TRGNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

110.58M

5-year avg

144.82M

10-year avg

161.17M

Transgene S.A. (TRGNF) Enterprise Value vs. Peers

How is TRGNF’s Enterprise Value compared to its peers?

Transgene S.A.’s Enterprise Value is less than Hansa Biopharma AB (publ) (3.05B), less than Silence Therapeutics plc (311.42M), less than Cellectis S.A. (301.02M), greater than Immutep Limited (149.97K), less than Genfit S.A. (523.85M), greater than hVIVO plc (55.42M), less than Santhera Pharmaceuticals Holding AG (298.98M), less than Mayne Pharma Group Limited (167.39M), less than Probi AB (publ) (3.69B), less than Oryzon Genomics S.A. (231.80M),

Build a custom stock screener for Transgene S.A. (TRGNF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Transgene S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Transgene S.A. (TRGNF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Transgene S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Transgene S.A.'s Enterprise Value?

What is the highest Enterprise Value for Transgene S.A. (TRGNF)?

What is the 3-year average Enterprise Value for Transgene S.A. (TRGNF)?

What is the 5-year average Enterprise Value for Transgene S.A. (TRGNF)?

How does the current Enterprise Value for Transgene S.A. (TRGNF) compare to its historical average?